We are very sorry but it looks like you are using an outdated browser. We strongly recommend updating to a modern browser.
More information about your browser and how to update

Exiqon

Exiqon combines leading-edge scientific expertise in gene expression with our proprietary LNA™ technology. Our products, services and scientific staff enable life science researchers to make groundbreaking discoveries. Moreover, we are addressing the unmet need for a new approach to the diagnosis of cancer.
 

Exiqon markets its products directly on www.exiqon.com, or through distributors, and partners its proprietary Locked Nucleic Acids (LNA) and Anthraquinone (AQ) technologies through industry leaders. Exiqon is located in the Medicon Valley area of Copenhagen, Denmark.
 

In December 2006, Exiqon A/S obtained ISO 9001:2000 certification for its quality management system standards in development, production, sales and support for products and services for gene activities analysis. 

Due to the broad applicability of Exiqons proprietary technologies, Exiqon has chosen the following partners for its products and technologies:


Roche Diagnostics
Luminex Corporation
Invitrogen
Fischer Scientific International Inc.

Details


Address:
Exiqon

Skelstedet 16
2950 Vedbaek
Denmark
Field of Activity:
Research & Education
Expansion:
international
Website:
Number of employess:
51-500
Founding year:
1996